These success, along with a former report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 guidance the concept of targeting ACKR3 as a novel method to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Conditions. A exploration study revealed in https://elbertg924hhg6.iyublog.com/profile